4.1 Article

Identification of Postpartum Depression

期刊

CLINICAL OBSTETRICS AND GYNECOLOGY
卷 52, 期 3, 页码 456-468

出版社

LIPPINCOTT WILLIAMS & WILKINS
DOI: 10.1097/GRF.0b013e3181b5a57c

关键词

postpartum depression; identification; screening tools

资金

  1. National Institute of Mental Health [R01 MH60335, K23 MH082114-01 A2, R01 MH071825, R01 MH075921]
  2. International Society of Bipolar Disorders Fellowship Award
  3. Society for Bariatric Surgery
  4. Heinz Foundation
  5. New York-Mid-Atlantic Consortium for Genetics and Newborn Screening Services
  6. Novogyne
  7. Pfizer
  8. Stanley Medical Research Foundation
  9. State of Pennsylvania
  10. NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH071825, R01MH060335, K23MH082114, R01MH075921] Funding Source: NIH RePORTER

向作者/读者索取更多资源

Postpartum depression (PPD) is the most common medical complication of childbearing. Universal screening maximizes the likelihood of prompt identification of PPD. Obstetrician-gynecologists routinely evaluate postpartum women for a general health examination and review of family planning options at approximately 6 weeks after birth; therefore, they are well positioned to identify PPD. In this study, we review the diagnostic criteria for postpartum depressive disorders and clinical risk factors predictive of PPD. We examine depression screening tools, appropriate cut-points associated with positive screens, the optimal timing for screening, and the acceptability of depression screening in obstetrical settings. Finally, we explore how to manage patients who screen positive for depression and treatment options for women with PPD.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.1
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据